Study reveals insights into GLP-1 drug effectiveness across sexes
A new study has uncovered fundamental sex-based differences in how weight loss medications interact with human biology, revealing why women experience more severe side effects from GLP-1 drugs such as Ozempic and Zepbound. Founded by leading neuroscientists and computational biologists in 2023, Olio Labs uses a novel… Read More